Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 1,188 | 4,771 | 302 | 737 | 899 |
| Gross Profit | 1,188 | 4,771 | 302 | 737 | 1,478 |
| Operating Expenses | 3,400 | 2,091 | 2,261 | 2,903 | 1,236 |
| Operating Income | -2,212 | 2,680 | -1,959 | -2,166 | -337 |
| Interest Expense | 377 | 366 | 597 | 515 | 542 |
| Other Income | 3,511 | -1,788 | 289 | 217 | 91 |
| Pre-tax Income | 922 | 526 | -2,267 | -2,464 | -788 |
| Net Income Continuous | 922 | 526 | -2,267 | -2,464 | -788 |
| Net Income Discontinuous | -38 | N/A | -6,880 | -686 | -1,448 |
| Net Income | $884 | $526 | $-9,147 | $-3,150 | $-2,236 |
| EPS Basic Total Ops | 8,002.25 | -11.24 | -7,747.38 | -3,343.33 | 2,556.22 |
| EPS Basic Continuous Ops | 3,258.61 | 238.39 | -1,919.04 | -2,616.19 | 4,520.91 |
| EPS Basic Discontinuous Ops | -1,324.76 | N/A | -5.83 | -727.14 | -1,915.29 |
| EPS Diluted Total Ops | 8,002.25 | -11.24 | -7,747.38 | -3,343.33 | 2,556.22 |
| EPS Diluted Continuous Ops | 3,258.61 | 238.39 | -1,919.04 | -2,616.19 | 4,520.91 |
| EPS Diluted Discontinuous Ops | -1,324.76 | N/A | -5.83 | -727.14 | -1,915.29 |
| EBITDA(a) | $-1,898 | $2,938 | $-1,696 | $-1,555 | $397 |